Skip to content

Tag: Postpartum depression

Explore our medication guides and pharmacology articles within this category.

Does Pitocin Affect Your Mood? Understanding the Connection

4 min read
In a 2017 study published in *Depression and Anxiety*, researchers found that women exposed to Pitocin during childbirth had a 32% to 36% increased risk of being diagnosed with a depressive or anxiety disorder in the first postpartum year. The question, **Does pitocin affect your mood?**, is a crucial area of research, with growing evidence suggesting a link to potential impacts on maternal mental health.

Why is Zurzuvae Addictive? Understanding its Abuse Potential

3 min read
As a Schedule IV controlled substance, Zurzuvae (zuranolone) has a known potential for abuse, misuse, and dependence, making the question of **why is zurzuvae addictive** a critical consideration for both prescribers and patients. This classification is based on pharmacological evidence showing that its active ingredient produces subjective effects with abuse potential.

Does Zurzuvae help with anxiety? The evidence behind its effect on PPD-related symptoms

3 min read
According to a clinical study published in *The American Journal of Psychiatry*, over 50% of women with postpartum depression treated with zuranolone experienced significant improvements in both depressive and anxiety symptoms after 45 days. This rapid-acting oral medication raises the question, **does Zurzuvae help with anxiety** more broadly, or just as a symptom of PPD?

What Class of Drug is Zuranolone? Understanding the New Oral PPD Treatment

4 min read
In August 2023, the FDA approved zuranolone, the first oral medication specifically for postpartum depression (PPD), representing a significant advancement in mental health care. This breakthrough has led many to question: what class of drug is zuranolone, and how does its novel mechanism set it apart from traditional antidepressants?

Is sertraline safe for breastfeeding? An evidence-based guide

4 min read
The period prevalence of postpartum depression is a significant concern, affecting up to 21.9% of women in the first year after birth. For many experiencing mental health challenges, understanding the safety of medications like sertraline for breastfeeding is a critical step toward recovery and maternal well-being.

Is zurzuvae a controlled substance? Yes, Understanding Its Schedule IV Status

3 min read
Effective October 31, 2023, the Drug Enforcement Administration (DEA) officially placed Zurzuvae (zuranolone) into Schedule IV of the Controlled Substances Act, following its FDA approval for treating postpartum depression. This action confirmed that the medication, a prescription treatment for a serious condition, carries a degree of risk for abuse and dependence.

How Does Zurzuvae Make You Feel? A Look at the PPD Treatment

3 min read
Affecting roughly 1 in 8 women with a recent live birth, postpartum depression (PPD) is a significant health concern [1.2.6]. For many, the critical question is: **how does Zurzuvae make you feel?** This once-daily, 14-day oral treatment offers a new approach to managing PPD symptoms.